Western Standard Partners QP, L.P. 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Nov 27, 2020
Insider Transaction Report
Form 4
Andersen Eric
DirectorOther
Transactions
- Purchase
Common Stock
2020-11-24$3.65/sh+18,014$65,751→ 315,757 total(indirect: See footnote) - Purchase
Common Stock
2020-11-24$3.65/sh+51,074$186,420→ 873,088 total(indirect: See footnote)
Footnotes (2)
- [F1]The shares are directly held by WSP. The general partner of the Funds is Western Standard. The managing member of Western Standard and the portfolio manager to the Funds is Mr. Andersen. Each of Western Standard and Mr. Andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- [F2]The shares are directly held by WSP QP. The general partner of the Funds is Western Standard. The managing member of Western Standard and the portfolio manager to the Funds is Mr. Andersen. Each of Western Standard and Mr. Andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.